Our Services
We are committed to bridging the knowledge gap between neuropsychopharmacology and legal standards of evidence, equipping pharmaceutical companies, healthcare providers, and their counsel with specialized knowledge needed to navigate complex litigation and drug development challenges.
-
We guide pharmaceutical, device and digital neurotherapeutic innovators through the complex regulatory and scientific landscape of CNS drug development:
Novel Therapeutic Applications and Patent Strategies:
Novel therapeutics patent applications
Drug repurposing patent applications
Clinical data collection to support patent claims
Example: Oxytocin for compulsive/impulsive behaviors and autism spectrum disorders
Example: Memantine for compulsive/impulsive behaviors and autism spectrum disorders
Advisory Board Leadership:
Scientific Advisory Boards for neuropharmacological R&D
Data Safety Monitoring Boards for clinical trials
Regulatory Strategy:
Clinical trial design optimization
Endpoint selection and validation
FDA and Regulatory submission strategies
-
We deliver specialized expertise in pharmaceutical litigation, with a proven track record in:
Product Liability Cases:
Pramipexole association with pathological gambling
Abilify-related impulse control disorders
Maternal acetaminophen use linked to ADHD/ASD development
Intellectual Property Litigation:
Critical scientific analysis for patent disputes
Complex cases including Effexor XR patent challenges
Class Action Antitrust:
Price-fixing cases in psychiatric pharmaceuticals
Clomipramine market manipulation affecting OCD treatment access
We also invite you to also explore the diverse range of services offered at our clinical practice and research foundation.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!